Skip to main content
. 2020 Sep 1;5(36):22759–22771. doi: 10.1021/acsomega.0c01703

Table 2. MARK4 Inhibition and Human Cancer Cell Viability Profile of Compounds 4a4h.

compound MARK4 inhibition IC50 (μM) MCF-7 IC50 (μM) HepG2 IC50 (μM)
4a >20 37.32 38.53
4b >20 34.44 32.66
4c >20 32.54 33.22
4d >20 33.27 35.42
4e 18.45 23.32 21.54
4f >20 28.82 24.77
4g 16.22 22.54 25.32
4h 1.47 3.74 5.99